Compare FNRN & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FNRN | PROF |
|---|---|---|
| Founded | 1910 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 285.1M | 248.8M |
| IPO Year | 2000 | 2017 |
| Metric | FNRN | PROF |
|---|---|---|
| Price | $17.73 | $6.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $11.14 |
| AVG Volume (30 Days) | 87.4K | ★ 144.6K |
| Earning Date | 07-29-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 2.42 | ★ 25.89 |
| EPS | ★ 0.64 | N/A |
| Revenue | N/A | ★ $16,098,000.00 |
| Revenue This Year | N/A | $64.06 |
| Revenue Next Year | N/A | $64.17 |
| P/E Ratio | $27.56 | ★ N/A |
| Revenue Growth | N/A | ★ 50.73 |
| 52 Week Low | $15.93 | $4.91 |
| 52 Week High | $19.25 | $8.95 |
| Indicator | FNRN | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 62.52 | 47.32 |
| Support Level | $17.52 | $5.92 |
| Resistance Level | $17.88 | $7.04 |
| Average True Range (ATR) | 0.35 | 0.28 |
| MACD | 0.07 | 0.04 |
| Stochastic Oscillator | 80.51 | 57.50 |
First Northern Community Bancorp is a bank holding company for a community bank, First Northern Bank of Dixon. It conducts general banking activities, including collecting deposits and originating loans, and serves Solano, Yolo, Sacramento, Placer, El Dorado, and Contra Costa Counties. It offers a broad range of alternative investment products and services, equipment leasing, credit cards, merchant card processing, payroll services, and limited international banking services. The bank generates the majority of its revenue by providing various products and services to small and medium-sized businesses and individuals. including accepting demand, interest bearing transaction, savings, and time deposits, and making commercial, consumer, and real estate-related loans.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.